340 related articles for article (PubMed ID: 9693131)
1. Permanent exposure of mucin-secreting HT-29 cells to benzyl-N-acetyl-alpha-D-galactosaminide induces abnormal O-glycosylation of mucins and inhibits constitutive and stimulated MUC5AC secretion.
Hennebicq-Reig S; Lesuffleur T; Capon C; De Bolos C; Kim I; Moreau O; Richet C; Hémon B; Recchi MA; Maës E; Aubert JP; Real FX; Zweibaum A; Delannoy P; Degand P; Huet G
Biochem J; 1998 Aug; 334 ( Pt 1)(Pt 1):283-95. PubMed ID: 9693131
[TBL] [Abstract][Full Text] [Related]
2. Benzyl-N-acetyl-alpha-D-galactosaminide inhibits the sialylation and the secretion of mucins by a mucin secreting HT-29 cell subpopulation.
Delannoy P; Kim I; Emery N; De Bolos C; Verbert A; Degand P; Huet G
Glycoconj J; 1996 Oct; 13(5):717-26. PubMed ID: 8909998
[TBL] [Abstract][Full Text] [Related]
3. Characterization of mucins and proteoglycans synthesized by a mucin-secreting HT-29 cell subpopulation.
Huet G; Kim I; de Bolos C; Lo-Guidice JM; Moreau O; Hemon B; Richet C; Delannoy P; Real FX; Degand P
J Cell Sci; 1995 Mar; 108 ( Pt 3)():1275-85. PubMed ID: 7622610
[TBL] [Abstract][Full Text] [Related]
4. GalNAc-alpha-O-benzyl inhibits NeuAcalpha2-3 glycosylation and blocks the intracellular transport of apical glycoproteins and mucus in differentiated HT-29 cells.
Huet G; Hennebicq-Reig S; de Bolos C; Ulloa F; Lesuffleur T; Barbat A; Carrière V; Kim I; Real FX; Delannoy P; Zweibaum A
J Cell Biol; 1998 Jun; 141(6):1311-22. PubMed ID: 9628888
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of the glycosylation and alteration in the intracellular trafficking of mucins and other glycoproteins by GalNAcalpha-O-bn in mucosal cell lines: an effect mediated through the intracellular synthesis of complex GalNAcalpha-O-bn oligosaccharides.
Gouyer V; Leteurtre E; Zanetta JP; Lesuffleur T; Delannoy P; Huet G
Front Biosci; 2001 Oct; 6():D1235-44. PubMed ID: 11578961
[TBL] [Abstract][Full Text] [Related]
6. Effect of benzyl-alpha-GalNAc, an inhibitor of mucin glycosylation, on cancer-associated antigens in human colon cancer cells.
Huang J; Byrd JC; Yoon WH; Kim YS
Oncol Res; 1992; 4(11-12):507-15. PubMed ID: 1284381
[TBL] [Abstract][Full Text] [Related]
7. O-Glycosylation and cellular differentiation in a subpopulation of mucin-secreting HT-29 cell line.
Hennebicq-Reig S; Tetaert D; Soudan B; Kim I; Huet G; Briand G; Richet C; Demeyer D; Degand P
Exp Cell Res; 1997 Aug; 235(1):100-7. PubMed ID: 9281357
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of mucin synthesis by benzyl-alpha-GalNAc in KATO III gastric cancer and Caco-2 colon cancer cells.
Byrd JC; Dahiya R; Huang J; Kim YS
Eur J Cancer; 1995; 31A(9):1498-505. PubMed ID: 7577079
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of the O-glycan elongation limits MUC1 incorporation to cell membrane of human endometrial carcinoma cells.
Porowska H; Paszkiewicz-Gadek A; Anchim T; Wolczynski S; Gindzienski A
Int J Mol Med; 2004 Mar; 13(3):459-64. PubMed ID: 14767580
[TBL] [Abstract][Full Text] [Related]
10. Massive in vitro synthesis of tagged oligosaccharides in 1-benzyl-2-acetamido-2-deoxy-alpha-D-galactopyranoside treated HT-29 cells.
Zanetta JP; Gouyer V; Maes E; Pons A; Hemon B; Zweibaum A; Delannoy P; Huet G
Glycobiology; 2000 Jun; 10(6):565-75. PubMed ID: 10814698
[TBL] [Abstract][Full Text] [Related]
11. O-glycan biosynthesis in human colorectal adenoma cells during progression to cancer.
Vavasseur F; Dole K; Yang J; Matta KL; Myerscough N; Corfield A; Paraskeva C; Brockhausen I
Eur J Biochem; 1994 Jun; 222(2):415-24. PubMed ID: 8020479
[TBL] [Abstract][Full Text] [Related]
12. Expression and characterization of mucins associated with the resistance to methotrexate of human colonic adenocarcinoma cell line HT29.
Dahiya R; Lesuffleur T; Kwak KS; Byrd JC; Barbat A; Zweibaum A; Kim YS
Cancer Res; 1992 Sep; 52(17):4655-62. PubMed ID: 1511431
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of mucin glycosylation by aryl-N-acetyl-alpha-galactosaminides in human colon cancer cells.
Kuan SF; Byrd JC; Basbaum C; Kim YS
J Biol Chem; 1989 Nov; 264(32):19271-7. PubMed ID: 2509474
[TBL] [Abstract][Full Text] [Related]
14. Benzyl-N-acetyl-alpha-D-galactosaminide induces a storage disease-like phenotype by perturbing the endocytic pathway.
Ulloa F; Real FX
J Biol Chem; 2003 Apr; 278(14):12374-83. PubMed ID: 12538583
[TBL] [Abstract][Full Text] [Related]
15. An efficient approach for the characterization of mucin-type glycopeptides: the effect of O-glycosylation on the conformation of synthetic mucin peptides.
Hashimoto R; Fujitani N; Takegawa Y; Kurogochi M; Matsushita T; Naruchi K; Ohyabu N; Hinou H; Gao XD; Manri N; Satake H; Kaneko A; Sakamoto T; Nishimura S
Chemistry; 2011 Feb; 17(8):2393-404. PubMed ID: 21264968
[TBL] [Abstract][Full Text] [Related]
16. Role of sulfated O-linked glycoproteins in zymogen granule formation.
De Lisle RC
J Cell Sci; 2002 Jul; 115(Pt 14):2941-52. PubMed ID: 12082154
[TBL] [Abstract][Full Text] [Related]
17. Analysis of the specificity of sialyltransferases toward mucin core 2, globo, and related structures. identification of the sialylation sequence and the effects of sulfate, fucose, methyl, and fluoro substituents of the carbohydrate chain in the biosynthesis of selectin and siglec ligands, and novel sialylation by cloned alpha2,3(O)sialyltransferase.
Chandrasekaran EV; Xue J; Xia J; Chawda R; Piskorz C; Locke RD; Neelamegham S; Matta KL
Biochemistry; 2005 Nov; 44(47):15619-35. PubMed ID: 16300412
[TBL] [Abstract][Full Text] [Related]
18. The glycosylation of rat intestinal Muc2 mucin varies between rat strains and the small and large intestine. A study of O-linked oligosaccharides by a mass spectrometric approach.
Karlsson NG; Herrmann A; Karlsson H; Johansson ME; Carlstedt I; Hansson GC
J Biol Chem; 1997 Oct; 272(43):27025-34. PubMed ID: 9341141
[TBL] [Abstract][Full Text] [Related]
19. Differential effect of GalNAcalpha-O-bn on intracellular trafficking in enterocytic HT-29 and Caco-2 cells: correlation with the glycosyltransferase expression pattern.
Gouyer V; Leteurtre E; Delmotte P; Steelant WF; Krzewinski-Recchi MA; Zanetta JP; Lesuffleur T; Trugnan G; Delannoy P; Huet G
J Cell Sci; 2001 Apr; 114(Pt 8):1455-71. PubMed ID: 11282022
[TBL] [Abstract][Full Text] [Related]
20. Diverse glycosylation of MUC1 and MUC2: potential significance in tumor immunity.
Irimura T; Denda K; Iida Si; Takeuchi H; Kato K
J Biochem; 1999 Dec; 126(6):975-85. PubMed ID: 10578046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
